- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04899609
The Effects of Anger and Joy Expressions on Approach and Avoidance Behaviors in Healthy Volunteers
Behavioral Adaptation to Negative and Positive Social Signals in Healthy Volunteers
Social interactions are part of our daily lives. Communicating with others is a recurring choice which is based on emotional cues, such as facial expression. Our action must be adapted to the emotional state of our interlocutor, otherwise the investigators will have poor quality interactions An emotional stimulus would cause a conditioned response (innate reaction). Thus, the presence of an angry person would automatically trigger flight behavior. More recently, however, it has been envisioned that this same avoidance behavior could be the result of a goal-directed behvior. In this case, the avoidance behavior would be the result of an evaluation of the consequences of the selected action. These goal-directed behaviors are guided by a mental representation of consequences The project aims to study behavioral choices (approach and avoidance) in response to negative and positive social cues (anger and joy) in 40 healthy volunteers using a computerized neuropsychological task, and to determine wheter these choices are the result of goal-directed behavior.
The study also aims to assess the modulation of behavioral adaptation by the level of impulsivity, lonilness, empathy, and by the capcity to understand others' intenstions.
Studieoversigt
Status
Betingelser
Undersøgelsestype
Tilmelding (Forventet)
Kontakter og lokationer
Studiekontakt
- Navn: Emilie OLIE, MD PhD
- Telefonnummer: +33 4 67 33 85 81
- E-mail: e-olie@chu-montpellier.fr
Undersøgelse Kontakt Backup
- Navn: Nathan RISCH, MD (intern)
- E-mail: risch.nathan@gmail.com
Studiesteder
-
-
-
Montpellier, Frankrig, 34295
- Rekruttering
- University Hospital
-
Kontakt:
- Emilie OLIE, MD PhD
- Telefonnummer: 33 4 67 33 82 89
- E-mail: e-olie@chu-montpellier.fr
-
Kontakt:
- Myriam BENRAMDANE
- Telefonnummer: 33 4 99 61 45 75
- E-mail: m-benramdane@chu-montpellier.fr
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion criteria:
- Being between 18 and 65 years old
- Absence of psychiatric pathology over the entire life
- Being able to understand the nature, purpose and methodology of the study
Exclusion criteria:
- Mental retardation or sever medical co-morbidity
- Sensory or cognitive disability
- Pregnant or breastfeeding woman
- Protection by law (guardianship or curatorship)
- Deprivation of liberty (by judicial or administrative decision)
- Exclusion period in relation to another protocol
- Inability to understand, speak and write French
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: Kohorte
- Tidsperspektiver: Tværsnit
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Percentage of approach and avoidance behavior in response to positive (joy) and negative (anger) social signals
Tidsramme: 1 day
|
Calculation of the proportion of avoidance vs. approach choices
|
1 day
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Response time
Tidsramme: 1 day
|
Computerized measurement of reaction time before clicking to make the avoidance or approach choice
|
1 day
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Studieleder: Emilie Olie, MD PhD, University Hospital, Montpellier
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- RECHMPL21_0304
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Major Depressive Episode
-
ACADIA Pharmaceuticals Inc.RekrutteringDepressiv lidelse, behandlingsresistent | Major Depressive Disorder (MDD)Forenede Stater
-
Rotman Research Institute at BaycrestRekrutteringMajor Depressive Disorder (MDD)Canada
-
Yonggui YuanIkke rekrutterer endnuMajor Depressive Disorder (MDD)Kina
-
Daniel LindqvistLund University; KetabonRekrutteringMajor Depressive Disorder (MDD)Sverige
-
King's College LondonCardiff and Vale University Health Board; South London and Maudsley NHS... og andre samarbejdspartnereRekrutteringMajor Depressive Disorder (MDD)Det Forenede Kongerige
-
Supernus Pharmaceuticals, Inc.RekrutteringMajor Depressive Disorder (MDD)Forenede Stater
-
University of PennsylvaniaRekruttering
-
University of PretoriaIkke rekrutterer endnuMajor Depressive Disorder (MDD)Saudi Arabien
-
Tel Aviv UniversityIkke rekrutterer endnuMajor Depressive Disorder (MDD)Israel
-
The Second Hospital of Anhui Medical UniversityIkke rekrutterer endnu